In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 27 for your search:
Drug:  muromonab-CD3
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: CUCCC-90-C01, NCI-V91-0009

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: STLMC-BRM-9502, NCI-V95-0764

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: BRMP-8707B, NCI-87-C-99B, NCI-T87-0175N, T87-0175

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: SVMC-ONC-121, NCI-V90-0206, NCT00002482

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: E203/2004, IRB Project Nr. 21/2004, HSZ-001, NCT00202917

6.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: KUMC-5699-93, NCI-V94-0426

7.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 5 to 65
Sponsor: NCI
Protocol IDs: RPCI-DS-96-67, NCI-G97-1247

8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: PPMC-IRB-94-53, OCC-ONC-9513-L, NCI-V98-1378

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067241, P30CA022453, WSU-C-1403-ME, NCI-G99-1565, NCT00004022

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067243, P30CA022453, WSU-C-1403-BT, NCI-G99-1567, NCT00004024

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 2 to 21
Sponsor: Other
Protocol IDs: HAPREF, NCT00143559

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 45 and under
Sponsor: NCI, Other
Protocol IDs: 1965.00, R01AI053193, P30CA015704, FHCRC-1965.00, CDR0000533834, 6428, NCT00450983

13.

Phase: Phase II
Type: Treatment
Status: Closed
Age: Over 16
Sponsor: NCI
Protocol IDs: CDR0000063744, STLMC-BRM-9401, NCI-V94-0514, NCT00002589

14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: 040152, 04-C-0152, NCT00080353

15.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CRB-9404, NCI-T93-0197N, T93-0197

16.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-96-C-0134, CRB-9302, NCI-T93-0171N, T93-0171

17.

Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: 93-0426.cc, UCHSC-COMIRB-93426, NCI-T94-0065O, T94-0065, NCT00002572

18.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-96-C-0131, CRB-9207, NCI-T94-0083N, T94-0083

19.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 13 and over
Sponsor: Other
Protocol IDs: STLMC-BRM-9501, NCI-V95-0735

20.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-8805B, NCI-89-C-44B, NCI-T88-0269N, T88-0269

21.

Phase: Phase I
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: MDA-ID-88024, NCI-T88-0268D, T88-0268

22.

Phase: Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: WCCC-CO-8991, NCI-B89-0004, B89-0004

23.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: LUMC-T90-0044, NCI-T90-0044O, T90-0044

24.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-8920H, NCI-90-C-128H, NCI-T90-0017N, T90-0017

25.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCUM-9018, NCI-T90-0148D, T90-0148
1   
New Search